Finanza

Notizie Discussioni Tecnici Previsione Stagionalità Opzioni

Flusso di cassa su Revolution Medicines, Inc..

Dati annuali

2018

2019

2020

2021

2022

2023

2024

TTM

‪‪−600,00 M‬‬

‪‪−450,00 M‬‬

‪‪−300,00 M‬‬

‪‪−150,00 M‬‬

‪0,00‬

Periodo

Valore

Variazione

Variazione %

TTM

‪‪−567,74 M‬‬

‪0,00‬

‪0,00‬%

2024

‪‪−567,74 M‬‬

‪‪−209,44 M‬‬

‪−58,45‬%

2023

‪‪−358,30 M‬‬

‪‪−123,08 M‬‬

‪−52,33‬%

2022

‪‪−235,22 M‬‬

‪‪−81,51 M‬‬

‪−53,03‬%

2021

‪‪−153,71 M‬‬

‪‪−50,71 M‬‬

‪−49,24‬%

2020

‪‪−103,00 M‬‬

‪‪−50,79 M‬‬

‪−97,29‬%

2019

2018

Dati trimestrali

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−180,00 M‬‬

‪‪−135,00 M‬‬

‪‪−90,00 M‬‬

‪‪−45,00 M‬‬

‪0,00‬

Periodo

Valore

Variazione

Variazione %

Q4 '24

‪‪−139,51 M‬‬

‪‪−5,57 M‬‬

‪−4,16‬%

Q3 '24

‪‪−133,94 M‬‬

‪‪−3,37 M‬‬

‪−2,58‬%

Q2 '24

‪‪−130,57 M‬‬

+‪‪33,16 M‬‬

+‪20,25‬%

Q1 '24

‪‪−163,73 M‬‬

‪‪−40,85 M‬‬

‪−33,24‬%

Q4 '23

‪‪−122,88 M‬‬

‪‪−19,85 M‬‬

‪−19,26‬%

Q3 '23

‪‪−103,03 M‬‬

‪‪−34,79 M‬‬

‪−50,98‬%

Q2 '23

‪‪−68,24 M‬‬

‪‪−4,09 M‬‬

‪−6,38‬%

Q1 '23

‪‪−64,15 M‬‬

+‪‪515,00 K‬‬

+‪0,80‬%

Q4 '22

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20

Q4 '19

Q3 '19

Q2 '19

Q1 '19